Contact Us

Global Automation In Biopharma Industry Market Trends 2025, Forecast To 2034

4 Mar, 2025

How Has The Automation In Biopharma Industry Market Size Evolved Historically?

The automation in biopharma industry market has seen considerable growth due to a variety of factors.
•The market size for automation in the biopharma industry has been experiencing a robust growth over recent years. The market, which is expected to be worth $2.08 billion in 2024, is predicted to expand to $2.2 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.9%.
The unprecedented growth noted in the historical period is traced back to the heightened complexity of biopharmaceutical processes, the necessity for enhancing process efficiency, the escalating development and manufacturing of biologics, the rising demand for quality assurance and control, and the mounting pressure to hasten time-to-market.

What Will Be The Automation In Biopharma Industry Market Size In The Future?

The automation in biopharma industry market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for automation in the biopharma industry is projected to experience significant growth in the upcoming years, reaching a value of $2.92 billion in 2029 with a compound annual growth rate (CAGR) of 7.4%.
Such growth during the estimation period can be linked to factors such as improved data integrity and documentation procedures, an increase in personalized medicine, the emergence of modular and flexible bioprocessing facilities, the development of automation platforms, a surge in biosimilars' demand, and the application of smart sensors and the internet of things (IoT). Some notable trends anticipated during the forecast period include the progression in robotics and automation technologies, advancements in single-use technologies, the inclusion of artificial intelligence in bioprocessing, improvements in process analytical technologies (PAT), partnerships between biopharma and tech firms, and a focus on sustainability in biopharma automation.

What Key Factors and Trends are Driving the Growth of the Automation In Biopharma Industry Market?

The surge in the use of robots in the manufacture of pharmaceuticals is predicted to drive the expansion of automation in the biopharma industry market. Pharmaceutical manufacturing robots are high-tech automated machines and systems that execute a variety of tasks in the creation and packaging of pharmaceutical products. They are frequently employed in various aspects of pharmaceutical manufacturing, including secondary packaging, intralogistics, laboratory automation, pick and place, pharmacy process automation, and personalized medical treatments. These applications result in increased productivity, enhanced accuracy, minimized contamination risks, and improved employee safety. For example, in September 2024, the Germany-based nonprofit professional organization, the International Federation of Robotics, reported a 9% increase in industrial robot installations in the manufacturing industry in Europe, reaching an all-time high of 92,393 units. 80% of these, or 73,534 units, were installed within the European Union—a 2% increase from the previous year. As a result, the rising utilization of robots in the manufacture of pharmaceuticals is expected to stimulate the expansion of the biopharma industry automation market.

What are the Market Segments in the Automation In Biopharma Industry Market?

The automation in biopharma industry market covered in this report is segmented –
1) By Technology: Automation Technology, Digitization Technology
2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase
3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase Subsegments:
1) By Automation Technology: Process Automation, Laboratory Automation, Robotics And Artificial Intelligence, Control Systems, Programmable Logic Controllers (PLCs)
2) By Digitization Technology: Data Analytics And Visualization, Electronic Lab Notebooks (ELN), Cloud Computing, Internet Of Things (IoT) In Pharma, Digital Twin Technology

Pre-Book The Automation In Biopharma Industry Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:

What Trends are Shaping the Automation In Biopharma Industry Market?

In the automation in biopharma industry market, a principal trend emerging is the progress in technology. Key industry players are concentrating on the design and development of cutting-edge product technologies to consolidate their market standing. For example, in September 2022, scientific solutions provider PerkinElmer Inc., introduces Cellaca PLX Image Cytometry System, an innovative automatic cell analysis solution geared to streamline cell and gene therapy research and manufacturing. This platform facilitates researchers in assessing crucial quality attributes such as identity, quantity, and quality in cell samples via an automated procedure. This holistic system brings together image cytometer hardware, software, validated consumables, and traceable data reporting, making calibration and training processes effortless.

Who Are the Key Players in the Automation In Biopharma Industry Market?

Major companies operating in the automation in biopharma industry market include:
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• ABB Ltd
• Siemens Healthineers AG
• Emerson Electric Co.
• Becton Dickinson and Company (BD)
• Corning Incorporated
• Rockwell Automation Inc.
• Agilent Technologies Inc.
• PerkinElmer Inc.
• Sartorius AG
• bioMérieux SA
• Mettler-Toledo International Inc.
• Beckman Coulter Inc.
• Waters Corporation
• Pall Corporation
• Bruker Corporation
• Qiagen N.V.
• Eppendorf AG
• Tecan Group Ltd.
• Promega Corporation
• Brooks Automation Inc.
• Omron Automation
• Hamilton Company
• Integra Biosciences AG
• Gilson Inc.
• Analytik Jena AG
• BioTek Instruments Inc.

What are the Regional Insights into the Automation In Biopharma Industry Market?

North America was the largest region in the automation in biopharma industry market in 2024. The regions covered in the automation in biopharma industry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa